Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

BCR-ABL Tyrosine Kinase Inhibition

Inactivation of wild-type BCR/ABL tyrosine kinase in hematopoietic cells by mild hyperthermia

Leukemia volume 14, pages 845–852 (2000)Cite this article

Abstract

Temperature-sensitive mutants of BCR/ABL tyrosine kinase have been extensively used to study the mechanisms of cell transformation and signal transduction. However, little is known about the effect of temperature on the activity of wild-type BCR/ABL gene product. In this study, we demonstrate that in vivo tyrosine kinase activity of p210, p190 BCR/ABL and v-abl are temperature-sensitive when expressed in hematopoietic cells and decline when temperature is raised 2°C above normal range. In vitro tyrosine kinase activities of purified recombinant Abl and immunoprecipitated p210 BCR/ABL were also sensitive to increased temperature. Tyrosine phosphorylation of cellular proteins was markedly reduced in BCR/ABL transformed cells after 16 h at 39°C, whereas the expression of BCR/ABL was unchanged. Temperature-induced downregulation of BCR/ABL kinase activity was reversible when cells were shifted back to 37°C. The downregulation of Abl tyrosine kinase activity was not influenced by mutation or deletion of SH2 or SH3 domains or mutation of the GRB2 binding site. No increase in functional activity or expression of protein-tyrosine phosphatases, PTP-1B, SH-PTP1 or SH-PTP2 was detected in cells grown at 39°C. Temperature-induced downregulation in tyrosine kinase activity correlated with decline in phosphotyrosine-associated PI 3-kinase whereas there was no change in growth factor independence of transformed hematopoietic cells. In conclusion, Abl tyrosine kinase has intrinsic sensitivity to temperature and BCR/ABL expressed in hematopoietic cells is downregulated by increasing temperature 2°C. These observations provide a unique opportunity to identify cellular factor(s) which regulate BCR/ABL kinase in vivo and suggests possible novel treatment of CML by a mild hyperthermia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Ramakrishnan L, Rosenberg N . abl genes Biochim Biophys Acta 1989 989: 209–224

    CAS  PubMed  Google Scholar 

  2. Wiedemann LM, Karhi KK, Shivji MK, Rayter SI, Pegram SM, Dowden G, Bevan D, Will A, Galton DA, Chan LC . The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases Blood 1988 71: 349–355

    CAS  PubMed  Google Scholar 

  3. Daley GQ, Van Etten RK, Baltimore D . Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome Science 1990 247: 824–830

    Article  CAS  Google Scholar 

  4. Daley GQ, Baltimore D . Transformation of an interleukin-3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 bcr/abl protein Proc Natl Acad Sci USA 1988 85: 9312–9316

    Article  CAS  Google Scholar 

  5. Lugo TG, Pendergast AM, Muller AJ, Witte ON . Tyrosine kinase activity and transformation potency of bcr-abl oncogene products Science 1990 247: 1079–1082

    Article  CAS  Google Scholar 

  6. Cortez D, Kadlec L, Pendergast AM . Structural and signalling requirements for BCR-ABL mediated transformation and inhibition of apoptosis Mol Cell Biol 1995 15: 5531–5541

    Article  CAS  Google Scholar 

  7. Hariharan IK, Adams JM, Cory S . BCR-abl oncogene renders myeloid cell line factor independent Oncogene 1988 3: 387–399

    CAS  Google Scholar 

  8. Nishii K, Kabarowski JHS, Gibbons DL, Griffiths SD, Titley I, Wiedemann LM, Greaves MF . ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block Oncogene 1996 13: 2225–2234

    CAS  PubMed  Google Scholar 

  9. Cortez D, Stoica G, Pierce JH, Pendergast AM . The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway Oncogene 1996 13: 2589–2594

    CAS  PubMed  Google Scholar 

  10. Cortez D, Reuther G, Pendergast AM . The BCR/abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to S phase transition in hematopoietic cells Oncogene 1997 15: 2333–2342

    Article  CAS  Google Scholar 

  11. Albrecht T, Schwab R, Henkes M, Peschel C, Huber C, Aulitzky WE . Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal Br J Haematol 1996 95: 501–507

    Article  CAS  Google Scholar 

  12. Bedi A, Barber JP, Bedi GC, El-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ . BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood 1995 86: 1148–1158

    CAS  PubMed  Google Scholar 

  13. Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG . BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner Oncogene 1998 16: 349–357

    Article  Google Scholar 

  14. Maguer-Satta V, Burl S, Liu L, Damen J, Chahine H, Krystal G, Eaves A, Eaves C . BCR-ABL accelerates C2-ceramide-induced apoptosis Oncogene 1998 16: 237–248

    Article  CAS  Google Scholar 

  15. Engelman A, Rosenberg N . Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis Proc Natl Acad Sci USA 1987 84: 8021–8025

    Article  CAS  Google Scholar 

  16. Engelman A, Rosenberg N . Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity J Virol 1990 64: 4242–4251

    CAS  PubMed  PubMed Central  Google Scholar 

  17. LaMontagne KRJ, Flint AJ, Franza RB, Pendergast AM, Tonks NK . Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo Mol Cell Biol 1998 18: 2965–2975

    Article  CAS  Google Scholar 

  18. Carlesso N, Griffin JD, Drucker B . Use of temperature-sensitive mutant to define the biological effects of p210/BCR/abl tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line Oncogene 1994 9: 149–156

    CAS  PubMed  Google Scholar 

  19. Kabarowski JHS, Allen PB, Wiedemann LM . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells EMBO J 1994 13: 5887–5895

    Article  CAS  Google Scholar 

  20. Cristau B, Schafer P, Pierce S . Heat shock enhances antigen processing and accelerates the formation of compact class II αβ dimers J Immunol 1994 152: 1546–1556

    CAS  PubMed  Google Scholar 

  21. Duff GW, Durum SK . T cell proliferation induced by interleukin 1 is greatly increased by hyperthermia Clin Res 1982 30: 694–699

    Google Scholar 

  22. Kappel M, Diamant M, Hansen MB, Klokker M, Pedersen BK . Effects of in vitro hyperthermia on the proliferative response of blood mononuclear subsets and detection of interleukin 1 and 6, tumor necrosis factor alpha and interferon-gamma Immunology 1991 73: 304–308

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Huang YH, Haegerstrand A, Frostegard J . Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity Clin Exp Immunol 1996 103: 61–66

    Article  CAS  Google Scholar 

  24. Palacios R, Steinmetz M . IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo Cell 1985 41: 727–734

    Article  CAS  Google Scholar 

  25. McLaughlin J, Chianese E, Witte ON . In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome Proc Natl Acad Sci USA 1987 84: 6558–6562

    Article  CAS  Google Scholar 

  26. Daley GQ, McLaughlin J, Witte ON, Baltimore D . The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts Science 1987 237: 532–535

    Article  CAS  Google Scholar 

  27. Varticovski L, Daley GQ, Jackson P, Baltimore D, Cantley LC . Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants Mol Cell Biol 1991 11: 1107–1113

    Article  CAS  Google Scholar 

  28. Varticovski L, Druker B, Morrison D, Cantley LC, Roberts T . The CSF-1 receptor associates with and activates PI 3-kinase Nature 1989 342: 699–702

    Article  CAS  Google Scholar 

  29. Susa M, Keeler ML, Varticovski L . Platetet-derived growth factor activates membrane-associated phosphatidyinositol 3-kinase and mediates its translocation from the cytosol J Biol Chem 1992 267: 22951–22956

    CAS  PubMed  Google Scholar 

  30. Jain SK, Susa-Spring M, Carlesso N, Druker B, Varticovski L . PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl Blood 1996 88: 1542–1550

    CAS  PubMed  Google Scholar 

  31. Sattler M, Salgia R, Shrikhande G, Verma S, Choi JL, Rohrschneider LR, Griffin JD . The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors Oncogene 1997 15: 2379–2384

    Article  CAS  Google Scholar 

  32. Jain SK, Langdon WY, Varticovski L . Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced Association with phosphatidylinositol 3-kinase Oncogene 1997 14: 2217–2228

    Article  CAS  Google Scholar 

  33. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B . Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood 1995 86: 726–736

    CAS  PubMed  Google Scholar 

  34. Klucher KM, Lopez DV, Daley GQ . Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression Blood 1998 91: 3927–3934

    CAS  PubMed  Google Scholar 

  35. Fincham VJ, Wyke JA . Localization of temperature-sensitive transformation mutations and back mutations in the Rous sarcoma virus src gene J Virol 1986 58: 694–699

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Lugo TG, Witte ON . The bcr/abl oncogene transforms Rat-1 cells and cooperates with c-myc Mol Cell Biol 1989 9: 1263–1270

    Article  CAS  Google Scholar 

  37. Jackson P, Baltimore D . N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl EMBO J 1989 8: 449–456

    Article  CAS  Google Scholar 

  38. Daley GQ, Van Etten RA, Jackson PK, Bernards A, Baltimore D . Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line Mol Cell Biol 1992 12: 1864–1871

    Article  CAS  Google Scholar 

  39. Skorski T, Kanakaraj P, Skoska MN, Ratajczak MZ, Wen S-C, Zon G, Gewirtz AM, Perussia B, Calabretta B . Phosphatidylinositol 3-kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells Blood 1995 86: 726–736

    CAS  PubMed  Google Scholar 

  40. Pendergast A-M, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky ML . BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein Cell 1993 75: 175–185

    Article  CAS  Google Scholar 

  41. Pendergast A, Muller AJ, Havlik MH, Maru Y, Witte ON . BCR sequences essential for transformation by the BCR-ABL oncogene bind to the Abl SH2 regulatory domain in a non-phosphotyrosine-dependent manner Cell 1991 66: 161–171

    Article  CAS  Google Scholar 

  42. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N . BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice Blood 1995 86: 4603–4611

    CAS  PubMed  Google Scholar 

  43. Varticovski L, Harrison-Findik D, Keeler ML, Susa M . Role of PI 3-kinase in mitogenesis Biochim Biophys Acta 1994 1226: 1–11

    Article  CAS  Google Scholar 

  44. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B . Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway EMBO J 1997 16: 6151–6161

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. SK Jain and I de Aos: These authors contributed equally to this work

Authors and Affiliations

  1. Department of Medicine, St Elizabeth's Medical Center, Tufts University School of Medicine, CBR 419, 736 Cambridge Street, Boston, MA 02135, USA

    SK Jain, I de Aos, Y Inai, F Liu & L Varticovski

Authors
  1. SK Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I de Aos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Inai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Varticovski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, S., de Aos, I., Inai, Y. et al. Inactivation of wild-type BCR/ABL tyrosine kinase in hematopoietic cells by mild hyperthermia. Leukemia 14, 845–852 (2000). https://doi.org/10.1038/sj.leu.2401759

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401759

Keywords

Search

Advanced search

Quick links